索引超出了数组界限。
[1] 中国医师协会高血压专业委员会, 中华医学会呼吸病学分会睡眠呼吸障碍学组. 阻塞性睡眠呼吸暂停相关性高血压临床诊断和治疗专家共识[J]. 中国呼吸与危重监护杂志, 2013, 12(5):435-441.
[2] Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing[J]. J Am Coll Cardiol, 2008, 52(8):686-717.
[3] Di Murro A, Petramala L, Cotesta D, et al. Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism[J]. J Renin Angiotensin Aldosterone Syst, 2010, 11(3):165-172.
[4] Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2016, 101(5):1889-1916.
[5] Jin ZN, Wei YX. Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system[J]. J Geriatr Cardiol, 2016, 13(4):333-343.
[6] Barceló A, Piérola J, Esquinas C, et al. Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment[J]. PLoS One, 2014, 9(1):e84362.
[7] Gonzaga CC, Gaddam KK, Ahmed MI, et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension[J]. J Clin Sleep Med, 2010, 6(4):363-368.
[8] Muxfeldt ES, Margallo VS, Guimaraes GM, et al. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension[J]. Am J Hypertens, 2014, 27(8):1069-1078.
[9] Sim JJ, Yan EH, Liu IL, et al. Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population[J]. J Hypertens, 2011, 29(8):1553-1559.
[10] 杨丽睿, 孙 腾, 张慧敏, 等. 难治性高血压患者阻塞性睡眠呼吸暂停综合征与醛固酮水平的相关性[J]. 中华高血压杂志, 2013, 21(11):1028-1032.
[11] Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry[J]. J Clin Endocrinol Metab, 2009, 94(4):1125-1130.
[12] Prejbisz A, Florczak E, Klisiewicz AA, et al. Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension[J]. Endokrynol Pol, 2013, 64(5):363-367.
[13] Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea[J]. Acta Physiol Scand, 2003, 177(3):385-390.
[14] 王广发. 阻塞性睡眠呼吸暂停低通气综合征的临床表现[J]. 中华结核和呼吸杂志, 2003, 26(5):262-263.
[15] Dinh Cat AN, Friederich-Persson M, White A, et al. Adipocytes, aldosterone and obesity-related hypertension[J]. J Mol Endocrinol, 2016, 57(1):F7-F21.
[16] Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone[J]. J Hum Hypertens, 2012, 26(5):281-287.
[17] Kasai T, Bradley TD, Friedman O, et al. Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension[J]. J Hypertens, 2014, 32(3):673-680.